Results 111 to 120 of about 11,052 (225)

Elevated cardiovascular risk associated with hormone replacement therapy: A comprehensive analysis of reproductive factors and atherosclerotic cardiovascular disease outcomes in the UK Biobank cohort

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 11, Page 2183-2194, November 2026.
Among 170,250 UK Biobank women (2006–2024), ever HRT use was associated with higher incident ASCVD risk (adjusted HR 1.13, 95% CI 1.08–1.18), largely driven by ischemic stroke. Associations were stronger in women ≤45 years and during perimenopause. Mediation via sex hormones, inflammatory markers, or lipids was minimal (<2%).
Mengchun Wang   +6 more
wiley   +1 more source

Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland

open access: yesActa Ophthalmologica, Volume 104, Issue 7, Page 742-749, November 2026.
Abstract Purpose Hormonal replacement therapy (HRT) in postmenopausal women appears to affect glaucoma risk, but findings are inconsistent. We aimed to explore whether the use of postmenopausal HRT plays a role in glaucoma development in Finland. Methods The main outcome variable was glaucoma incidence measured by initiation of special reimbursement ...
Sirpa Loukovaara, Jari Haukka
wiley   +1 more source

Does the use of hormonal contraceptives induce negative metacognitions, brooding, and depressive symptoms in an adolescent community sample? [PDF]

open access: yesCompr Psychoneuroendocrinol
Kennair LEO   +7 more
europepmc   +1 more source

Basal body temperature as a biomarker of reproductive state in ewes: A multi‐method comparison

open access: yesAustralian Veterinary Journal, Volume 104, Issue 11, Page 734-741, November 2026.
This study quantified body temperature dynamics throughout reproductive stages in crossbred ewes based on complementary monitoring techniques. Five ewes from a semi‐extensive farming system were included in two sub‐trials: animals were first assessed in the prepubertal stage and, subsequently, an oestrous cycle was induced by intravaginal progesterone ...
E Pérez‐García   +4 more
wiley   +1 more source

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

open access: yesJournal of Internal Medicine, Volume 300, Issue 5, Page 590-609, November 2026.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund   +5 more
wiley   +1 more source

Impact of Hormonal Contraceptive Exposure on Pancreatic &beta;-Cell Adaptation and Glucose Homeostasis: A Systematic Review

open access: yesOpen Access Journal of Contraception
Aime Patrick Niyomugabo, Olufunke Onaadepo, Leopold Ntakirutimana, Muluken Walle Birhanie, Onyinye Cynthia Okeke, Abdul-Rahuf Aderemi Feyitimi, Ejike Daniel Eze, Abdulazeez Jimoh, Abdullateef Isiaka Alagbonsi, Makinde Vincent OlubiyiDepartment of Medical
Niyomugabo AP   +9 more
doaj  

Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep. [PDF]

open access: yesJ Obstet Gynaecol Res
Hirose A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy